601089 福元医药
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.49312.81713.93614.71620.014
总资产报酬率 ROA (%)1.9369.63710.43711.02113.556
投入资产回报率 ROIC (%)2.44112.47913.34813.87018.263

边际利润分析
销售毛利率 (%)61.69565.51367.08966.63568.234
营业利润率 (%)12.80915.22815.74516.52914.709
息税前利润/营业总收入 (%)12.83714.59914.65314.92514.120
净利润/营业总收入 (%)11.85913.44814.28114.74213.568

收益指标分析
经营活动净收益/利润总额(%)87.90998.10293.23397.22397.099
价值变动净收益/利润总额(%)4.9703.3641.9940.3320.573
营业外收支净额/利润总额(%)0.145-1.970-0.447-0.5211.922

偿债能力分析
流动比率 (X)3.1842.9042.6903.3343.203
速动比率 (X)2.7442.5112.3983.0262.881
资产负债率 (%)21.19422.97326.17123.55526.447
带息债务/全部投入资本 (%)0.351-0.2191.5383.3354.417
股东权益/带息债务 (%)27,833.233-44,884.6556,276.9052,848.4782,115.690
股东权益/负债合计 (%)370.470334.114281.191323.772277.724
利息保障倍数 (X)1,504.181-43.582-14.335-9.830-16.094

营运能力分析
应收账款周转天数 (天)43.95339.39736.60940.02540.801
存货周转天数 (天)121.318113.223103.965104.438115.964